Modular Medical Announces Proof-of-Concept Study for Personalized Metabolic Therapy utilizing the MODD1 Platform

Stock Information for Modular Medical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Modular Medical Inc.

Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1
Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology
Modular Medical Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the MODD1 Platform
Registration Is Now Open For Tribe Public's Webinar Event "Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity" Featuring Modular Medical CEO On Wednesday, September 11, 2024
Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump
Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump
Registration is Now Open for Tribe Public's Webinar Event "Diabetes Care Innovator Modular Medical Takes Next Steps" Featuring Modular Medical CEO on Friday, August 9, 2024
Modular Medical Announces Addition to the Russell Microcap(R) Index

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.